Koh A - Search Results

1

Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice.

Ribas A, Butterfield LH, Hu B, Dissette VB, Meng WS, Koh A, Andrews KJ, Lee M, Amar SN, Glaspy JA, McBride WH, Economou JS. Ribas A, et al. Among authors: koh a. Cancer Res. 2000 Apr 15;60(8):2218-24. Cancer Res. 2000. PMID: 10786687

2

Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.

Vollmer CM Jr, Eilber FC, Butterfield LH, Ribas A, Dissette VB, Koh A, Montejo LD, Lee MC, Andrews KJ, McBride WH, Glaspy JA, Economou JS. Vollmer CM Jr, et al. Among authors: koh a. Cancer Res. 1999 Jul 1;59(13):3064-7. Cancer Res. 1999. PMID: 10397245

3

Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.

Butterfield LH, Koh A, Meng W, Vollmer CM, Ribas A, Dissette V, Lee E, Glaspy JA, McBride WH, Economou JS. Butterfield LH, et al. Among authors: koh a. Cancer Res. 1999 Jul 1;59(13):3134-42. Cancer Res. 1999. PMID: 10397256

4

Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells.

Ribas A, Butterfield LH, McBride WH, Dissette VB, Koh A, Vollmer CM, Hu B, Chen AY, Glaspy JA, Economou JS. Ribas A, et al. Among authors: koh a. Cancer Gene Ther. 1999 Nov-Dec;6(6):523-36. doi: 10.1038/sj.cgt.7700076. Cancer Gene Ther. 1999. PMID: 10608349

5

Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells.

Ribas A, Butterfield LH, Hu B, Dissette VB, Chen AY, Koh A, Amarnani SN, Glaspy JA, McBride WH, Economou JS. Ribas A, et al. Among authors: koh a. J Immunother. 2000 Jan;23(1):59-66. doi: 10.1097/00002371-200001000-00008. J Immunother. 2000. PMID: 10687138

6

T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein.

Butterfield LH, Meng WS, Koh A, Vollmer CM, Ribas A, Dissette VB, Faull K, Glaspy JA, McBride WH, Economou JS. Butterfield LH, et al. Among authors: koh a. J Immunol. 2001 Apr 15;166(8):5300-8. doi: 10.4049/jimmunol.166.8.5300. J Immunol. 2001. PMID: 11290817

7

Parathyroid hormone-related protein as a growth regulator of prostate carcinoma.

Dougherty KM, Blomme EA, Koh AJ, Henderson JE, Pienta KJ, Rosol TJ, McCauley LK. Dougherty KM, et al. Among authors: koh aj. Cancer Res. 1999 Dec 1;59(23):6015-22. Cancer Res. 1999. PMID: 10606251

8

Parathyroid hormone-related protein drives a CD11b+Gr1+ cell-mediated positive feedback loop to support prostate cancer growth.

Park SI, Lee C, Sadler WD, Koh AJ, Jones J, Seo JW, Soki FN, Cho SW, Daignault SD, McCauley LK. Park SI, et al. Cancer Res. 2013 Nov 15;73(22):6574-83. doi: 10.1158/0008-5472.CAN-12-4692. Epub 2013 Sep 26. Cancer Res. 2013. PMID: 24072746 Free PMC article.

9

Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells.

Chen HL, Demiralp B, Schneider A, Koh AJ, Silve C, Wang CY, McCauley LK. Chen HL, et al. Among authors: koh aj. J Biol Chem. 2002 May 31;277(22):19374-81. doi: 10.1074/jbc.M108913200. Epub 2002 Mar 15. J Biol Chem. 2002. PMID: 11897779 Free article.

10

Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions.

Liao J, Li X, Koh AJ, Berry JE, Thudi N, Rosol TJ, Pienta KJ, McCauley LK. Liao J, et al. Int J Cancer. 2008 Nov 15;123(10):2267-78. doi: 10.1002/ijc.23602. Int J Cancer. 2008. PMID: 18729185 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

779 results

Search Page

Filters